$3.60
5.57% today
NYSE, Oct 20, 07:49 pm CET
ISIN
US67080N1019
Symbol
NUVB

Nuvation Bio Inc - Ordinary Shares - Class A Stock price

$3.41
+0.15 4.60% 1M
+1.44 73.10% 6M
+0.75 28.20% YTD
+0.98 40.33% 1Y
+1.18 52.91% 3Y
-7.55 68.89% 5Y
-6.59 65.90% 10Y
-6.59 65.90% 20Y
NYSE, Closing price Fri, Oct 17 2025
-0.22 6.06%
ISIN
US67080N1019
Symbol
NUVB
Industry

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$761.0m
Net debt
positive
Cash
$607.7m
Shares outstanding
342.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
81.5 | 38.0
EV/Sales
53.0 | 24.7
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
85.8%
Return on Equity
-122.5%
ROCE
-38.7%
ROIC
-3,052.1%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$14.4m | $30.8m
EBITDA
$-223.6m | -
EBIT
$-224.6m | $-249.5m
Net Income
$-202.9m | $-226.3m
Free Cash Flow
$-168.6m
Growth (TTM | estimate)
Revenue
897.2% | 291.3%
EBITDA
-99.2% | -
EBIT
-99.3% | -48.9%
Net Income
60.3% | 60.2%
Free Cash Flow
-100.1%
Margin (TTM | estimate)
Gross
27.5%
EBITDA
-1,557.6% | -
EBIT
-1,564.9%
Net
-1,413.4% | -734.7%
Free Cash Flow
-1,174.4%
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
34.3%
Employees
220
Rev per Employee
$40.0k
Show more

Is Nuvation Bio Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Nuvation Bio Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

Buy
93%
Hold
7%

Financial data from Nuvation Bio Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14 14
897% 897%
100%
- Direct Costs 10 10
670% 670%
72%
3.95 3.95
4,289% 4,289%
28%
- Selling and Administrative Expenses 120 120
225% 225%
833%
- Research and Development Expense 109 109
43% 43%
759%
-224 -224
99% 99%
-1,557%
- Depreciation and Amortization 1.05 1.05
156% 156%
7%
EBIT (Operating Income) EBIT -225 -225
99% 99%
-1,564%
Net Profit -203 -203
60% 60%
-1,413%

In millions USD.

Don't miss a Thing! We will send you all news about Nuvation Bio Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuvation Bio Inc - Ordinary Shares - Class A Stock News

Positive
The Motley Fool
20 days ago
Shares of Nuvation Bio (NUVB 14.13%) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday.
Neutral
Business Wire
20 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it has enrolled the first patient in TRUST-IV (NCT07154706), a Phase 3 study evaluating the efficacy and safety of IBTROZI™ (taletrectinib), a next-generation ROS1 inhibitor, versus placebo for the adjuvant treatment of pat...
Positive
Seeking Alpha
21 days ago
Today, I am highlighting three biotech stocks I like in the current market that are trading at under $10.00 a share. The options on these stocks are also lucrative and liquid, making them well-suited for consistent covered call trades. Covered call strategies offer downside protection in the underperforming, high-beta biotech sector, supporting a rinse, wash, and repeat approach.
More Nuvation Bio Inc - Ordinary Shares - Class A News

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Head office United States
CEO David Hung
Employees 220
Founded 2018
Website www.nuvationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today